First Affiliated Hospital of Xian Jiantong University
Xi'an, Shaanxi, 710061, China
NCT Number: NCT05694273
This study aims to evaluate the incidence, clinical characteristics, and short-term prognosis of acute cerebrovascular events occurring in-hospital in patients with arrhythmias following catheter ablation. The goal is to provide evidence supporting the improvement of patient quality of life and reduction of in-hospital acute cerebrovascular complications in patients with post-ablation arrhythmias. This will also contribute to the evidence-based clinical management of such patients.
Trial opening soon.
Get Notified18 year–80 year
All sexes
Observational
Xi'an, Shaanxi, 710061, China
With the steady development of catheter ablation, it has gradually become the main treatment of various arrhythmias. Antithrombotic and anticoagulant therapy after catheter ablation determines the occurrence of perioperative bleeding and ischemic events. However, the incidence, characteristics and short-term prognosis of secondary acute cerebrovascular events in patients with arrhythmia after catheter ablation have not been studied. Methods: This study was intended to retrospectively collect and analyze the case data and auxiliary examination results of patients with arrhythmia who underwent catheter ablation. To evaluate the incidence, clinical features and short-term prognosis of secondary acute ischemic and hemorrhagic cerebrovascular events in patients with arrhythmia after catheter ablation. In order to improve the quality of life of patients, reduce the secondary acute cerebrovascular complications in the hospital in patients with arrhythmia after catheter ablation, to provide evidence for promoting the clinical management of such patients, and to provide help for the maximum degree of prevention and control risk.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months after enrollment
Major adverse cardiovascular and cerebrovascular events, a composite of all-cause mortality, myocardial infarction and stroke. The data will be obtained at 3-month follow-up, according to medical records of all patients.
Time frame: 3 months after enrollment
The data will be obtained at 3-month follow-up, according to medical records of all patients.
Time frame: 3 months after enrollment
The data will be obtained at 3-month follow-up, according to medical records of all patients.
Time frame: 3 months after enrollment
The data will be obtained at 3-month follow-up, according to medical records of all patients.
Contact information is provided by the study sponsor or research team.
First Affiliated Hospital Xi'an Jiaotong University
Other
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation (CENTRAL): an Investigator-initiated, Multicenter Real-world Study
Acronym: CENTRAL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07675434
Acute Coronary Syndrome, Acute Coronary Syndromes
View Trial DetailsNCT07491237
Arrhythmia, Arrhythmias, Cardiac
View Trial DetailsNCT07395089
Arrhythmia, Arrhythmias, Cardiac
Paris, Île-de-France Region, France
View Trial DetailsNCT07389928
Arrhythmia, Arrhythmias, Cardiac
View Trial Details